0

Journal Articles

in Drug/Vaccine Safety
 21-40 of 90 Articles
Research Letters |  February 20, 2013
Pharmaceutical Overdose Deaths, United States, 2010
Christopher M. Jones, PharmD; Karin A. Mack, PhD; Leonard J. Paulozzi, MD
JAMA. 2013;309(7):657-659. doi:10.1001/jama.2013.272.
Medical News and Perspectives |  February 20, 2013
FDA Warning: Driving May Be Impaired the Morning Following Sleeping Pill Use
Bridget M. Kuehn, MSJ
JAMA. 2013;309(7):645-646. doi:10.1001/jama.2013.323.
Editorial |  February 13, 2013
Antibiotics for Skin Infections:  New Study Design and a Step Toward Shorter Course Therapy
Shira Doron, MD; Helen W. Boucher, MD
JAMA. 2013;309(6):609-611. doi:10.1001/jama.2013.604.
Editorial |  February 13, 2013 FREE
Restoring Confidence in the Pharmaceutical Industry
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2013;309(6):607-609. doi:10.1001/jama.2013.58.
From the Centers for Disease Control and Prevention |  February 13, 2013
Buprenorphine Prescribing Practices and Exposures Reported to a Poison Center—Utah, 2002-2011
JAMA. 2013;309(6):536-538. doi:10.1001/jama.2012.217206.
JAMA Clinical Evidence Synopsis |  February 06, 2013
Opioid Analgesics for Rheumatoid Arthritis Pain
Samuel L. Whittle, MBBS, MClinEpi; Bethan L. Richards, MBBS, MClinEpi; Rachelle Buchbinder, MBBS, PhD
JAMA. 2013;309(5):485-486. doi:10.1001/jama.2012.193412.
Lab Reports |  February 06, 2013
Safer Cancer Drug
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.269.
Health Agencies Update |  January 23, 2013
Telaprevir Warning
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.22.
Health Agencies Update |  January 23, 2013
Varenicline Safety Notice
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.16.
Medical News and Perspectives |  January 16, 2013
Hospital Faces Uncertainty as It Copes With Surge of Patients With Fungal Meningitis
Bridget M. Kuehn, MSJ
JAMA. 2013;309(3):219-221. doi:10.1001/jama.2012.187705.
Viewpoint |  January 16, 2013
Mega-Trials for Blockbusters
John P. A. Ioannidis, MD, DSc
JAMA. 2013;309(3):239-240. doi:10.1001/jama.2012.168095.
Original Contribution |  January 02, 2013
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Olof Stephansson, MD, PhD; Helle Kieler, MD, PhD; Bengt Haglund, PhD; et al.
JAMA. 2013;309(1):48-54. doi:10.1001/jama.2012.153812.
INCLUDES: , Supplemental Content
Health Agencies Update |  December 26, 2012
Challenge to Alzheimer Drug
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2557. doi:10.1001/jama.2012.156122.
Medical News and Perspectives |  December 26, 2012 FREE
Unsafe Injection Practices Plague US Outpatient Facilities, Harm Patients
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2551-2552. doi:10.1001/jama.2012.114239.
Viewpoint |  December 19, 2012
Fungal Meningitis From Injection of Contaminated Steroids:  A Compounding Problem
Lucy E. Wilson, MD, ScM; David Blythe, MD, MPH; Joshua M. Sharfstein, MD
JAMA. 2012;308(23):2461-2462. doi:10.1001/jama.2012.47932.
From the Centers for Disease Control and Prevention |  December 12, 2012 FREE
Multistate Outbreak of Fungal Infection Associated with Injection of Methylprednisolone Acetate Solution from a Single Compounding Pharmacy—United States, 2012
JAMA. 2012;308(22):2328-2331. doi:10.1001/jama.2012.64944.
Research Letters |  October 10, 2012 FREE
Off-Label Use of Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis
Emily Dodwell, MD, MPH; Brian Snyder, MD, PhD; James Wright, MD, MPH
JAMA. 2012;308(14):1429-1432. doi:10.1001/jama.2012.12929.
Viewpoint |  October 10, 2012
The FDA Safety and Innovation Act
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.
Viewpoint |  September 05, 2012
The Safety Risks of Innovation:  The FDA's Expedited Drug Development Pathway
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.
Viewpoint |  September 05, 2012
Clinical Trial Data as a Public Good
Marc A. Rodwin, JD, PhD; John D. Abramson, MD, MS
JAMA. 2012;308(9):871-872. doi:10.1001/jama.2012.9661.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Dermatology
Practice Gaps  |  April 01, 2013
Propranolol to Treat Hemangiomas of Infancy:  Safety and Side Effect Recognition
Comment on “Retrospective Review of Adverse Effects from Propranolol in Infants”
Jonathan A. Dyer, MD
JAMA Dermatology
Research Letters  |  April 01, 2013
Retrospective Review of Adverse Effects From Propranolol in Infants
Eun-Kyung M. Kwon, BA; Shawna Joachim, BA; Dawn H. Siegel, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems